Cardiol Therapeutics (CRDL) Interest & Investment Income (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Interest & Investment Income came in at $146369.1 in Q1 2026, down 15.4% YoY from $173022.8 in Q1 2025, and up 16.5% on a QoQ basis from $125640.0 in Q4 2025.
Cardiol Therapeutics (CRDL) Interest & Investment Income (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Interest & Investment Income data on file, last reported at $146369.1 in Q1 2026.
- Quarterly Interest & Investment Income fell 15.4% year-over-year to $146369.1 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $491234.2 (down 35.82% YoY) and the FY2025 annual result came in at $520892.2, down 39.02% from the prior year.
- Interest & Investment Income climbed to $146369.1 in Q1 2026, from $125640.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $430711.2 in Q4 2022 to a low of $57087.8 in Q1 2022.
- A 5-year average of $234367.5 and a median of $219604.6 in 2024 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income surged 1855.24% — and 2024, when it slumped 61.52%.
- Tracing CRDL's Interest & Investment Income over 5 years: stood at $430711.2 in 2022, then declined by 23.55% to $329294.5 in 2023, then plunged by 33.31% to $219604.6 in 2024, then tumbled by 42.79% to $125640.0 in 2025, then rose by 16.5% to $146369.1 in 2026.
- The last three Interest & Investment Income figures came in at $146369.1 (Q1 2026), $125640.0 (Q4 2025), and $88835.5 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cardiol Therapeutics | 215.50 Mn | 196.65 Mn | - | 145,547.99 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 146,369.08 |
| Dec 31, 2025 | 125,639.97 |
| Sep 30, 2025 | 88,835.49 |
| Jun 30, 2025 | 130,389.63 |
| Mar 31, 2025 | 173,022.76 |
| Dec 31, 2024 | 219,604.62 |
| Sep 30, 2024 | 147,977.09 |
| Jun 30, 2024 | 224,759.18 |
| Mar 31, 2024 | 279,994.86 |
| Dec 31, 2023 | 329,294.48 |
| Sep 30, 2023 | 384,555.50 |
| Jun 30, 2023 | 393,589.78 |
| Mar 31, 2023 | 403,820.22 |
| Dec 31, 2022 | 430,711.16 |
| Sep 30, 2022 | 298,523.45 |
| Jun 30, 2022 | 150,072.60 |
| Mar 31, 2022 | 57,087.76 |
| Dec 31, 2021 | 22,028.56 |
| Sep 30, 2021 | 28,543.13 |
| Jun 30, 2021 | 20,728.67 |